Purpose The purpose of this article was to analyze the results of studies in the literature,
which evaluated the use of endothelial progenitor cells (EPCs) as a cell-based tissue …

Inadequate blood supply frequently impedes the viability of tissue-engineered constructs in
the initial phase after implantation, and can lead to improper cell integration or cell death …

For tissue engineering applications, effective bone regeneration requires rapid neo‐
vascularization of implanted grafts to ensure the survival of cells in the early post …

Purpose Treating fracture nonunion with endothelial progenitor cells (EPCs) is a promising
approach. Nevertheless, the effect of different EPC-related cell populations remains unclear …

Endothelial progenitor cells (EPCs) derived from bone marrow and blood can differentiate
into endothelial cells and promote neovascularization. In addition, EPCs are a promising cell …

Stem cells of various origins, particularly endothelial progenitor cells (EPCs), have potential
to enhance bone repair and regeneration. EPCs are resident in the bone marrow and home …

Endothelial progenitor cell (EPC) therapy has been successfully used in orthopaedic
preclinical models to heal bone defects. However, no previous studies have investigated the …

Fracture healing is a complex physiological process. Local vascularity at the site of the
fracture has been established as one of the most important factors influencing the healing …

In addition to its important transport functions, the skeletal system is involved in complex
biological activities for the regulation of blood vessels. Endothelial progenitor cells (EPCs) …

Recent evidences suggest that endothelial progenitor cells (EPCs) derived from bone
marrow (BM) contribute to de novo vessel formation in adults occurring as physiological and …